Glucon Inc.
Industry
- Biotechnology
- In Vitro Diagnostics
- Glucose Testing
See more in Biomedtracker
Latest on Glucon Inc.
Medtech Insight
Although venture capitalists are the shepherds of large pools of risk capital, they really don’t like to have to take anything on faith. So it doesn’t help that non-invasive consumer glucose monitorin
Medtech Insight
Mergers & Acquisitions Abbott Diagnostics (a division of Abbott Laboratories Inc.), Abbott Point of Care (a division of Abbott Laboratories Inc.) & GE Healthcare (a division of General Electric Co.) G
Medtech Insight
With an increasing emphasis on tight glycemic control in diabetes care, innovative devices will play a big role, as long as companies can find the right business models. Mary Stuart The race to offer